Symptoms and treatment options depend on the stage of your lung cancer along with what type of NSCLC you're diagnosed with. There are three primary types: adenocarcinoma, squamous cell carcinoma, and ...

Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

Air pollution might be playing an increasing role in causing the disease.

Volrustomig is under clinical development by AstraZeneca and currently in Phase III for Squamous Non-Small Cell Lung Cancer. According to GlobalData, Phase III drugs for Squamous Non-Small Cell Lung ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

Air pollution is the leading cause behind the rise in lung cancer cases among non-smokers, especially women and those living ...

The number of lung cancer diagnoses amongst people who have never smoked is increasing globally, according to the World ...

The study also found that the sub-type of lung cancer was also found to account for 53-70 per cent of lung cancer cases in ...

Non-small-cell lung cancer (NSCLC) is the most common type ... The three most common forms of NSCLC are adenocarcinoma, squamous cell carcinoma and large cell carcinoma. DeepGEM, an artificial ...

A new study has revealed the deadly cancer could be linked to a new factor as smoking rates continue to fall.